26.96

3.09% 0.91

Cassava Sciences Inc (SAVA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SAVA? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$26.05

Offen:

$26.13

24-Stunden-Volumen:

160.02K

Relative Volume:

0.10

Marktkapitalisierung:

$1.25B

Einnahmen:

Nettoeinkommen (Verlust:

$-97.22M

KGV:

-12.31

EPS:

-2.19

Netto-Cashflow:

$-82.44M

1W Leistung:

+2.74%

1M Leistung:

-7.01%

6M Leistung:

+20.59%

1J Leistung:

+20.37%

1-Tages-Spanne:

$26.03

$27.00

1-Wochen-Bereich:

$25.46

$29.49

52-Wochen-Spanne:

$8.79

$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Firmenname

Cassava Sciences Inc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

512-501-2444

Adresse

6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

SAVA's Discussions on Twitter

Vergleichen Sie SAVA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SAVA	26.82	1.25B	0	-97.22M	-82.44M	-2.19
VRTX	445.00	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	736.17	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	583.62	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.09	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.19	24.49B	3.30B	-501.07M	1.03B	11.54

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-11-16	Herabstufung	B. Riley Securities	Buy → Neutral
2021-07-15	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2021-07-07	Bestätigt	Maxim Group	Buy
2021-04-27	Eingeleitet	B. Riley Securities	Buy
2021-02-16	Bestätigt	H.C. Wainwright	Buy
2020-10-23	Eingeleitet	Cantor Fitzgerald	Overweight
2020-09-23	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-05-18	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-05-15	Herabstufung	Maxim Group	Buy → Hold
2020-01-10	Bestätigt	Maxim Group	Buy

Alle ansehen

Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten

Nov 19, 2024

Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year? - MSN

Nov 19, 2024

Nov 18, 2024

Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer - citybiz

Nov 18, 2024

Cassava Sciences, Inc. Appoints Freda Nassif as Chief Commercial Officer - Marketscreener.com

Nov 18, 2024

Nov 15, 2024

Anavex, Cassava Sciences, Panax Ginseng, And Long-Term Treatment Of Alzheimer's Disease - Seeking Alpha

Nov 11, 2024

Nov 10, 2024

How To Trade (SAVA) - Stock Traders Daily

Nov 10, 2024

Nov 09, 2024

Cassava Sciences, Inc. (NASDAQ:SAVA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Cassava Sciences (NASDAQ:SAVA) Issues Quarterly Earnings Results - MarketBeat

Nov 09, 2024

Cassava Sciences (NASDAQ:SAVA) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 09, 2024

Nov 08, 2024

Cassava Sciences Q3 2024 Earnings Preview - MSN

Nov 08, 2024

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla? - Benzinga

Nov 08, 2024

Another U.S. biotech based on Chinese science - STAT

Nov 08, 2024

Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting - Seeking Alpha

Nov 08, 2024

Cassava Sciences nears Alzheimer's drug trial results By Investing.com - Investing.com Canada

Nov 08, 2024

Cassava Sciences’ Q3 2024: Financials and Alzheimer’s Trials Progress - TipRanks

Nov 08, 2024

Nov 07, 2024

Cassava Sciences: Pivotal Alzheimer’s Data May Push Stock Toward Book Value (SAVA) - Seeking Alpha

Nov 07, 2024

Cassava Q3 Earnings Review: It Feels Like The End May Be Nigh (NASDAQ:SAVA) - Seeking Alpha

Nov 07, 2024

Looking At Cassava Sciences's Recent Unusual Options Activity - Benzinga

Nov 07, 2024

Cassava Sciences nears Alzheimer's drug trial results - Investing.com India

Nov 07, 2024

Cassava Sciences stock in focus after earnings (SAVA:NASDAQ) - Seeking Alpha

Nov 07, 2024

Cassava Sciences Reports Q3 2024 Financial and Operating Results - The Manila Times

Nov 07, 2024

Nov 06, 2024

Cassava Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024

Nov 05, 2024

Cassava Sciences (NASDAQ:SAVA) Trading Down 5.8%Should You Sell? - MarketBeat

Nov 05, 2024

Unpacking the Latest Options Trading Trends in Cassava Sciences - Benzinga

Nov 05, 2024

Nov 04, 2024

Analysts Believe Cassava Sciences Now Has 300% Upside From Here - MSN

Nov 04, 2024

Nov 01, 2024

Cassava Sciences (SAVA) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 01, 2024

Oct 31, 2024

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 - GlobeNewswire

Oct 31, 2024

International Assets Investment Management LLC Makes New Investment in Cassava Sciences, Inc. (NASDAQ:SAVA) - MarketBeat

Oct 31, 2024

Oct 30, 2024

Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value - Yahoo Finance

Oct 30, 2024

Long Term Trading Analysis for (SAVA) - Stock Traders Daily

Oct 30, 2024

Oct 26, 2024

HC Wainwright & Co. Upgrades Cassava Sciences (SAVA) - MSN

Oct 26, 2024

Oct 24, 2024

Cassava Sciences Options Trading: A Deep Dive into Market Sentiment - Benzinga

Oct 24, 2024

Oct 21, 2024

Institutions profited after Cassava Sciences, Inc.'s (NASDAQ:SAVA) market cap rose US$72m last week but individual investors profited the most - Simply Wall St

Oct 21, 2024

Oct 19, 2024

(SAVA) Proactive Strategies - Stock Traders Daily

Oct 19, 2024

Oct 17, 2024